C8 GBI Good Governance November 2021 Monthly Report – Cirdan Capital

Commentary

The certificate fell by 1% on the month.  The Good Governance premia had been making steady gains before falling, towards the end of the month, as volatility returned to US stocks (the certificate is already back higher in early December).

Looking at the performance of the underlying equities, Tech continues to perform well with Nvidia, HP and Apple the headline outperformers. There was underperformance in Healthcare, as Merck and Waters lost ground after last month’s sharp rise, whilst potential lawsuits against Activision have knocked that stock.

Overall positioning is unchanged in December, with a L/S of 2.25/1.85.

Other posts

Thoughts From The Divide: The Little Things

BY JON WEBB
Following the warnings from Walmart’s earnings last week, Target announced earnings this week and saw its stock walloped. As the CEO noted, “The ‘biggest challenges’ Target is hearing from its shoppers are ‘inflation in food and household essentials’”, further adding that “inflation is putting a ‘strain on the consumer wallet.’” Read more →

Thoughts From The Divide: The Moon

BY JON WEBB
If the Fed can “only know” the neutral rate (and hence whether policy is restrictive) “by its works”… there may be reason to think that the music is still playing. Whether it’s the price surges of misspelled celebrity memecoins ICOs such as “Joram Poowel” (a coin based on Elizabeth Warren was the “Top gainer” at the time of writing), the return of the Manufacturing PMI to positive territory “for the first time in 17 months”, or the simple good old fashioned break out of gold to all-time highs (sympathy to all mining stock bros, miners have failed to attract the same level of enthusiasm), the “restrictive” territory being bandied about seems less of a place of economic pain, and more one of milk and honey. Read more →

NDR Dynamic Allocation Strategy February 2023 Update

BY BRIAN SANBORN
Dynamic Allocation Strategy, indicators, weightings update Read more →
Back to all posts →